Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Iradimed (IRMD) Return on Capital Employed (2016 - 2025)

Historic Return on Capital Employed for Iradimed (IRMD) over the last 12 years, with Q3 2025 value amounting to 0.25%.

  • Iradimed's Return on Capital Employed changed 0.0% to 0.25% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.25%, marking a year-over-year change of 0.0%. This contributed to the annual value of 0.25% for FY2024, which is 200.0% down from last year.
  • According to the latest figures from Q3 2025, Iradimed's Return on Capital Employed is 0.25%, which was down 0.0% from 0.25% recorded in Q2 2025.
  • Iradimed's Return on Capital Employed's 5-year high stood at 0.27% during Q4 2023, with a 5-year trough of 0.0% in Q1 2021.
  • Its 5-year average for Return on Capital Employed is 0.2%, with a median of 0.24% in 2023.
  • Its Return on Capital Employed has fluctuated over the past 5 years, first crashed by -1200bps in 2021, then surged by 1500bps in 2022.
  • Quarter analysis of 5 years shows Iradimed's Return on Capital Employed stood at 0.13% in 2021, then soared by 59bps to 0.21% in 2022, then increased by 29bps to 0.27% in 2023, then dropped by -8bps to 0.25% in 2024, then increased by 2bps to 0.25% in 2025.
  • Its Return on Capital Employed stands at 0.25% for Q3 2025, versus 0.25% for Q2 2025 and 0.25% for Q1 2025.